내분비 검사 시장 규모, 점유율 및 성장 분석 : 기술별, 검체 유형별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Endocrine Testing Market size was valued at USD 13.8 Billion in 2024 and is poised to grow from USD 14.99 Billion in 2025 to USD 29.0 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The global endocrine testing market is largely propelled by the rising prevalence of hormone-related disorders, transforming these diagnostics into standard clinical practices. This field includes assays and platforms that assess hormone levels, autoantibodies, and metabolites to accurately diagnose conditions like diabetes, thyroid issues, and reproductive disorders. The significance of timely testing is underscored by its impact on treatment decisions and overall health outcomes. Advances in technology have progressed from basic bioassays to sophisticated automated systems, enhancing the sensitivity and multiplexing capabilities of tests. Moreover, regulatory clarity and increased reimbursement for chronic disease management are driving further investments. As telemedicine and home sampling methods improve accessibility, emerging economies present substantial opportunities for market growth and expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endocrine Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endocrine Testing Market Segments Analysis

Global endocrine testing market is segmented by technology, sample type, application, end user, distribution channel and region. Based on technology, the market is segmented into Immunoassay, Mass Spectrometry, Molecular Diagnostics, Clinical Chemistry and Others. Based on sample type, the market is segmented into Blood, Urine, Saliva and Others. Based on application, the market is segmented into Endocrine Disorder Diagnosis, Fertility Testing, Diabetes Management, Oncology Testing, Preventive Health Screening and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Specialty Clinics, Academic & Research Institutes and Others. Based on distribution channel, the market is segmented into Direct Sales, Distributors, Online Platforms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endocrine Testing Market

The increasing prevalence of endocrine disorders has heightened the demand for diagnostic testing within clinical settings. Healthcare providers are placing greater emphasis on disease management pathways, leading to an uptick in screening practices. This surge in diagnoses has also stimulated awareness among the clinical community regarding the necessity of routine monitoring. Consequently, hospitals and clinical laboratories have reported a significant rise in the utilization of hormonal panels and specialty assays. This ongoing demand necessitates investments in testing infrastructure, workflow integrations, and staff training in laboratories that conduct these evaluations, ultimately creating opportunities for market expansion. As accurate diagnosis is crucial in patient management, there will be a growing need for valid assays and related services, driving further use and commercialization of products aimed at diagnosing endocrine disorders.

Restraints in the Global Endocrine Testing Market

The Global Endocrine Testing market faces several significant restraints that hinder its advancement. High costs associated with advanced endocrine assays, including specialized instruments and reagent supplies, place a considerable financial strain on clinical laboratories and healthcare providers. This situation restricts the potential for widespread adoption of these technologies. Furthermore, substantial capital investments and ongoing maintenance requirements deter smaller laboratories, particularly in resource-constrained settings, from offering comprehensive testing services. Additionally, the perception of high per-test costs impacts purchasing decisions and budget allocations, resulting in prolonged procurement timelines and cautious approaches to scaling operations. Such economic pressures ultimately slow the adoption of new assays, hindering overall market growth.

Market Trends of the Global Endocrine Testing Market

The Global Endocrine Testing market is increasingly characterized by a shift towards personalized hormone profiling, driven by advancements in technology that enable rapid and efficient evaluation of hormone levels. This trend emphasizes individualized approaches to diagnosing, monitoring, and treating endocrine disorders, leveraging innovative biomarker scanning and multiplex assays. By aligning diagnostic testing with each patient's unique hormone function and symptoms, healthcare providers can optimize treatment strategies and enhance patient engagement. Additionally, the integration of longitudinal sample evaluations and patient-reported outcomes supports continuous monitoring and early identification of hormonal dysregulation, fostering collaboration between diagnostic developers and endocrinology specialists to create tailored, patient-specific care pathways.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Endocrine Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay
• Mass Spectrometry
• Molecular Diagnostics
• Clinical Chemistry
• Others

Global Endocrine Testing Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood
• Urine
• Saliva
• Others

Global Endocrine Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Endocrine Disorder Diagnosis
• Fertility Testing
• Diabetes Management
• Oncology Testing
• Preventive Health Screening
• Others

Global Endocrine Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Clinics
• Academic & Research Institutes
• Others

Global Endocrine Testing Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors
• Online Platforms
• Others

Global Endocrine Testing Market Size & CAGR (2026-2033)

• North America (Technology, Sample Type, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Technology, Sample Type, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Sample Type, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Sample Type, Application, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Sample Type, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations